CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
0.106
-0.006 (-4.92%)
Dec 3, 2024, 12:27 PM EST - Market open
CNS Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 5.02 | 4.77 | 5.97 | 4.68 | 4.39 | 1.98 | |
| Research & Development | 12.06 | 14.1 | 9.3 | 9.81 | 5.06 | 1.85 | |
| Operating Expenses | 17.08 | 18.87 | 15.27 | 14.49 | 9.45 | 3.83 | |
| Operating Income | -17.08 | -18.87 | -15.27 | -14.49 | -9.45 | -3.83 | |
| Interest Expense | -0.02 | -0.01 | -0.01 | -0.01 | -0 | -0.04 | |
| Interest & Investment Income | 0.04 | 0.03 | - | - | - | - | |
| EBT Excluding Unusual Items | -17.06 | -18.85 | -15.27 | -14.5 | -9.46 | -3.88 | |
| Pretax Income | -17.06 | -18.85 | -15.27 | -14.5 | -9.46 | -3.88 | |
| Net Income | -17.06 | -18.85 | -15.27 | -14.5 | -9.46 | -3.88 | |
| Net Income to Common | -17.06 | -18.85 | -15.27 | -14.5 | -9.46 | -3.88 | |
| Shares Outstanding (Basic) | 6 | 0 | 0 | 0 | 0 | - | |
| Shares Outstanding (Diluted) | 6 | 0 | 0 | 0 | 0 | - | |
| Shares Change (YoY) | 9861.66% | 176.66% | 55.02% | 58.58% | - | - | |
| EPS (Basic) | -2.99 | -250.19 | -560.83 | -825.04 | -853.68 | - | |
| EPS (Diluted) | -2.99 | -250.19 | -561.00 | -825.04 | -853.68 | - | |
| Free Cash Flow | -14.18 | -14.14 | -10.56 | -13.54 | -7.34 | -3.57 | |
| Free Cash Flow Per Share | -2.48 | -187.72 | -387.82 | -770.91 | -662.15 | - | |
| EBITDA | -17.08 | -18.86 | -15.26 | -14.47 | -9.44 | -3.83 | |
| D&A For EBITDA | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | |
| EBIT | -17.08 | -18.87 | -15.27 | -14.49 | -9.45 | -3.83 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.